Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.00909-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Dario Akaberi und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden. Hauptthemen laut MEDLINE: SARS-CoV-2, Coronavirus 3C Proteases, Antiviral Agents, Small Molecule Libraries. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scandinavian Society for Antimicrobial Chemotherapy Foundation (SSAC Foundation), Erik, Karin and Gösta Selander Foundation, Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation).
Abstract (Originalsprache)
In vitro screening of large compound libraries with automated high-throughput screening is expensive and time-consuming and requires dedicated infrastructures. Conversely, the selection of DNA-encoded chemical libraries (DECLs) can be rapidly performed with routine equipment available in most laboratories. In this study, we identified novel inhibitors of SARS-CoV-2 main protease (M pro ) through the affinity-based selection of the DELopen library (open access for academics), containing 4.2 billion compounds. The identified inhibitors were peptide-like compounds containing an N-terminal electrophilic group able to form a covalent bond with the nucleophilic Cys145 of M pro , as confirmed by x-ray crystallography. This DECL selection campaign enabled the discovery of the unoptimized compound SLL11 (IC 50 = 30 nM), proving that the rapid exploration of large chemical spaces enabled by DECL technology allows for the direct identification of potent inhibitors avoiding several rounds of iterative medicinal chemistry. As demonstrated further by x-ray crystallography, SLL11 was found to adopt a highly unique U-shaped binding conformation, which allows the N-terminal electrophilic group to loop back to the S1′ subsite while the C-terminal amino acid sits in the S1 subsite. MP1, a close analog of SLL11, showed antiviral activity against SARS-CoV-2 in the low micromolar range when tested in Caco-2 and Calu-3 (EC 50 = 2.3 µM) cell lines. As peptide-like compounds can suffer from low cell permeability and metabolic stability, the cyclization of the compounds will be explored in the future to improve their antiviral activity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Biochemistry and Microbiology, Zoonosis Science Center, Uppsala University, Uppsala, Sweden.
- Department of Medicinal Chemistry, Uppsala University, Uppsala, Sweden.
- Department of Medical Sciences, Clinical Microbiology, Uppsala University, Uppsala, Sweden.
- Center for ViroScience and Cure, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia, USA.
- Children's Healthcare of Atlanta, Atlanta, Georgia, USA.
- Department of Medical Biochemistry and Biophysics, Protein Science Facility, Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Dario Akaberi, Stefan G Sarafianos, Oscar Verho, Johan Lennerstrand
Förderung
- Scandinavian Society for Antimicrobial Chemotherapy Foundation (SSAC Foundation)
- Erik, Karin and Gösta Selander Foundation
- Knut och Alice Wallenbergs Stiftelse (Knut and Alice Wallenberg Foundation)
- Science for Life Laboratory (SciLifeLab)
- Wenner-Gren Foundations
Zitieren
APA
Akaberi, D., Pourghasemi Lati, M., Krambrich, J., Berger, J., Neilsen, G., Strandback, E., Turunen, S. P., Wannberg, J., Gullberg, H., Moche, M., Chinthakindi, P. K., Nyman, T., Sarafianos, S. G., Sandström, A., Järhult, J. D., Sandberg, K., Lundkvist, Å., Verho, O., & Lennerstrand, J. (2024). Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00909-24
Vancouver
Akaberi D, Pourghasemi Lati M, Krambrich J, Berger J, Neilsen G, Strandback E, et al. Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00909-24
BibTeX
@article{Akaberi2024,
author = {Akaberi, Dario and Pourghasemi Lati, Monireh and Krambrich, Janina and Berger, Julia and Neilsen, Grace and Strandback, Emilia and Turunen, S Pauliina and Wannberg, Johan and Gullberg, Hjalmar and Moche, Martin and Chinthakindi, Praveen Kumar and Nyman, Tomas and Sarafianos, Stefan G and Sandström, Anja and Järhult, Josef D and Sandberg, Kristian and Lundkvist, Åke and Verho, Oscar and Lennerstrand, Johan},
title = {Identification of novel and potent inhibitors of SARS-CoV-2 main protease from DNA-encoded chemical libraries},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.00909-24}
}
EUVIMED